Skin Boosters Comprehensive Study by Type (Mesotherapy, Micro-needle), End Users (Dermatology Clinics, Medspas), Gender (Female, Male) Players and Region - Global Market Outlook to 2032

Skin Boosters Market by XX Submarkets | Forecast Years 2025-2032  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Skin Boosters Market Overview:
The MMR Report demonstrates the market's strong growth, which has been driven by reasons including growing consumer awareness of skin health, a rise in the desire for cosmetic operations that need little invasiveness, and significant developments in skincare technologies. The report offers a comprehensive analysis of the Skin Boosters market, encompassing an exploration of market trends, growth catalysts, challenges, competitive dynamics, and future projections. The demand for less intrusive anti-aging treatments such as skin boosters is being driven by customers' increasing focus on self-care and preventive measures. In emerging economies, especially in the Asia Pacific, the aging population with discretionary income and growing awareness of beauty are also generating new consumer categories. Technological developments in formulations, delivery methods, and chemicals are improving therapies' efficacy and personalization while drawing in a larger consumer base. Additionally, the inclination towards natural and organic components including collagen and hyaluronic acid complements the makeup of skin boosters, driving market growth even more. Finally, skin boosters are becoming more popular than standard Botox and fillers because of changing consumer preferences for convenience, personalization, and non-surgical procedures. Prioritize product innovation through research & and development for innovative formulations and biocompatible ingredients targeting certain concerns to drive growth in the Skin Boosters market. Investing in innovative delivery technologies, such as biocompatible carriers or microneedle patches, increases efficacy and patient comfort. Stress individualized care by offering skin boosters that are specifically designed for each patient based on their skin type and demands. By acquiring natural ingredients ethically and responsibly, are expected to satisfy both regulatory obligations and consumer aspirations. For better accessibility and user experience, incorporate digital solutions like e-commerce platforms, AI-powered skin examination tools, and online consultations

AttributesDetails
Study Period2020-2032
Base Year2024
Forecast Period2025-2032
Historical Period2020-2024
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility

Competitive Landscape:

Some of the key players profiled in the report are Bloomage Biotech Co., Ltd. (China)​, Medytox, Inc. (South Korea)​, AbbVie Inc. (United States)​, Merz Pharma (Germany)​, Galderma (Switzerland)​, Teoxane (Switzerland) ​ and IBSA Farmaceutici Italia Srl (Italy) ​. Additionally, following companies can also be profiled that are part of our coverage like PharmaResearch Co., Ltd. (South Korea)​, Allergan ( Ireland)​, IBSA Institut Biochimique SA (Switzerland)​, HA Derma Filler (South Korea)​ and Filorga Laboratories (France). Analyst at AMA Research see Global Players to retain maximum share of Global Skin Boosters market by 2032. Considering Market by End Users, the sub-segment i.e. Dermatology Clinics will boost the Skin Boosters market. Considering Market by Gender, the sub-segment i.e. Female will boost the Skin Boosters market.

What Can be Explored with the Skin Boosters Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Skin Boosters Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Skin Boosters
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Skin Boosters market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Skin Boosters market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Mesotherapy
  • Micro-needle
By End Users
  • Dermatology Clinics
  • Medspas

By Gender
  • Female
  • Male

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Factor Analysis
    • 3.1. Porters Five Forces
    • 3.2. Supply/Value Chain
    • 3.3. PESTEL analysis
    • 3.4. Market Entropy
    • 3.5. Patent/Trademark Analysis
  • 4. Global Skin Boosters, by Type, End Users, Gender and Region (value) (2019-2024)
    • 4.1. Introduction
    • 4.2. Global Skin Boosters (Value)
      • 4.2.1. Global Skin Boosters by: Type (Value)
        • 4.2.1.1. Mesotherapy
        • 4.2.1.2. Micro-needle
      • 4.2.2. Global Skin Boosters by: End Users (Value)
        • 4.2.2.1. Dermatology Clinics
        • 4.2.2.2. Medspas
      • 4.2.3. Global Skin Boosters by: Gender (Value)
        • 4.2.3.1. Female
        • 4.2.3.2. Male
      • 4.2.4. Global Skin Boosters Region
        • 4.2.4.1. South America
          • 4.2.4.1.1. Brazil
          • 4.2.4.1.2. Argentina
          • 4.2.4.1.3. Rest of South America
        • 4.2.4.2. Asia Pacific
          • 4.2.4.2.1. China
          • 4.2.4.2.2. Japan
          • 4.2.4.2.3. India
          • 4.2.4.2.4. South Korea
          • 4.2.4.2.5. Taiwan
          • 4.2.4.2.6. Australia
          • 4.2.4.2.7. Rest of Asia-Pacific
        • 4.2.4.3. Europe
          • 4.2.4.3.1. Germany
          • 4.2.4.3.2. France
          • 4.2.4.3.3. Italy
          • 4.2.4.3.4. United Kingdom
          • 4.2.4.3.5. Netherlands
          • 4.2.4.3.6. Rest of Europe
        • 4.2.4.4. MEA
          • 4.2.4.4.1. Middle East
          • 4.2.4.4.2. Africa
        • 4.2.4.5. North America
          • 4.2.4.5.1. United States
          • 4.2.4.5.2. Canada
          • 4.2.4.5.3. Mexico
  • 5. Skin Boosters: Manufacturers/Players Analysis
    • 5.1. Competitive Landscape
      • 5.1.1. Market Share Analysis
        • 5.1.1.1. Top 3
    • 5.2. Peer Group Analysis (2024)
    • 5.3. BCG Matrix
    • 5.4. Company Profile
      • 5.4.1. Bloomage Biotech Co., Ltd. (China)​
        • 5.4.1.1. Business Overview
        • 5.4.1.2. Products/Services Offerings
        • 5.4.1.3. Financial Analysis
        • 5.4.1.4. SWOT Analysis
      • 5.4.2. Medytox, Inc. (South Korea)​
        • 5.4.2.1. Business Overview
        • 5.4.2.2. Products/Services Offerings
        • 5.4.2.3. Financial Analysis
        • 5.4.2.4. SWOT Analysis
      • 5.4.3. AbbVie Inc. (United States)​
        • 5.4.3.1. Business Overview
        • 5.4.3.2. Products/Services Offerings
        • 5.4.3.3. Financial Analysis
        • 5.4.3.4. SWOT Analysis
      • 5.4.4. Merz Pharma (Germany)​
        • 5.4.4.1. Business Overview
        • 5.4.4.2. Products/Services Offerings
        • 5.4.4.3. Financial Analysis
        • 5.4.4.4. SWOT Analysis
      • 5.4.5. Galderma (Switzerland)​
        • 5.4.5.1. Business Overview
        • 5.4.5.2. Products/Services Offerings
        • 5.4.5.3. Financial Analysis
        • 5.4.5.4. SWOT Analysis
      • 5.4.6. Teoxane (Switzerland) ​
        • 5.4.6.1. Business Overview
        • 5.4.6.2. Products/Services Offerings
        • 5.4.6.3. Financial Analysis
        • 5.4.6.4. SWOT Analysis
      • 5.4.7. IBSA Farmaceutici Italia Srl (Italy) ​
        • 5.4.7.1. Business Overview
        • 5.4.7.2. Products/Services Offerings
        • 5.4.7.3. Financial Analysis
        • 5.4.7.4. SWOT Analysis
  • 6. Global Skin Boosters Sale, by Type, End Users, Gender and Region (value) (2027-2032)
    • 6.1. Introduction
    • 6.2. Global Skin Boosters (Value)
      • 6.2.1. Global Skin Boosters by: Type (Value)
        • 6.2.1.1. Mesotherapy
        • 6.2.1.2. Micro-needle
      • 6.2.2. Global Skin Boosters by: End Users (Value)
        • 6.2.2.1. Dermatology Clinics
        • 6.2.2.2. Medspas
      • 6.2.3. Global Skin Boosters by: Gender (Value)
        • 6.2.3.1. Female
        • 6.2.3.2. Male
      • 6.2.4. Global Skin Boosters Region
        • 6.2.4.1. South America
          • 6.2.4.1.1. Brazil
          • 6.2.4.1.2. Argentina
          • 6.2.4.1.3. Rest of South America
        • 6.2.4.2. Asia Pacific
          • 6.2.4.2.1. China
          • 6.2.4.2.2. Japan
          • 6.2.4.2.3. India
          • 6.2.4.2.4. South Korea
          • 6.2.4.2.5. Taiwan
          • 6.2.4.2.6. Australia
          • 6.2.4.2.7. Rest of Asia-Pacific
        • 6.2.4.3. Europe
          • 6.2.4.3.1. Germany
          • 6.2.4.3.2. France
          • 6.2.4.3.3. Italy
          • 6.2.4.3.4. United Kingdom
          • 6.2.4.3.5. Netherlands
          • 6.2.4.3.6. Rest of Europe
        • 6.2.4.4. MEA
          • 6.2.4.4.1. Middle East
          • 6.2.4.4.2. Africa
        • 6.2.4.5. North America
          • 6.2.4.5.1. United States
          • 6.2.4.5.2. Canada
          • 6.2.4.5.3. Mexico
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Skin Boosters: by Type(USD Million)
  • Table 2. Skin Boosters Mesotherapy , by Region USD Million (2019-2024)
  • Table 3. Skin Boosters Micro-needle , by Region USD Million (2019-2024)
  • Table 4. Skin Boosters: by End Users(USD Million)
  • Table 5. Skin Boosters Dermatology Clinics , by Region USD Million (2019-2024)
  • Table 6. Skin Boosters Medspas , by Region USD Million (2019-2024)
  • Table 7. Skin Boosters: by Gender(USD Million)
  • Table 8. Skin Boosters Female , by Region USD Million (2019-2024)
  • Table 9. Skin Boosters Male , by Region USD Million (2019-2024)
  • Table 10. South America Skin Boosters, by Country USD Million (2019-2024)
  • Table 11. South America Skin Boosters, by Type USD Million (2019-2024)
  • Table 12. South America Skin Boosters, by End Users USD Million (2019-2024)
  • Table 13. South America Skin Boosters, by Gender USD Million (2019-2024)
  • Table 14. Brazil Skin Boosters, by Type USD Million (2019-2024)
  • Table 15. Brazil Skin Boosters, by End Users USD Million (2019-2024)
  • Table 16. Brazil Skin Boosters, by Gender USD Million (2019-2024)
  • Table 17. Argentina Skin Boosters, by Type USD Million (2019-2024)
  • Table 18. Argentina Skin Boosters, by End Users USD Million (2019-2024)
  • Table 19. Argentina Skin Boosters, by Gender USD Million (2019-2024)
  • Table 20. Rest of South America Skin Boosters, by Type USD Million (2019-2024)
  • Table 21. Rest of South America Skin Boosters, by End Users USD Million (2019-2024)
  • Table 22. Rest of South America Skin Boosters, by Gender USD Million (2019-2024)
  • Table 23. Asia Pacific Skin Boosters, by Country USD Million (2019-2024)
  • Table 24. Asia Pacific Skin Boosters, by Type USD Million (2019-2024)
  • Table 25. Asia Pacific Skin Boosters, by End Users USD Million (2019-2024)
  • Table 26. Asia Pacific Skin Boosters, by Gender USD Million (2019-2024)
  • Table 27. China Skin Boosters, by Type USD Million (2019-2024)
  • Table 28. China Skin Boosters, by End Users USD Million (2019-2024)
  • Table 29. China Skin Boosters, by Gender USD Million (2019-2024)
  • Table 30. Japan Skin Boosters, by Type USD Million (2019-2024)
  • Table 31. Japan Skin Boosters, by End Users USD Million (2019-2024)
  • Table 32. Japan Skin Boosters, by Gender USD Million (2019-2024)
  • Table 33. India Skin Boosters, by Type USD Million (2019-2024)
  • Table 34. India Skin Boosters, by End Users USD Million (2019-2024)
  • Table 35. India Skin Boosters, by Gender USD Million (2019-2024)
  • Table 36. South Korea Skin Boosters, by Type USD Million (2019-2024)
  • Table 37. South Korea Skin Boosters, by End Users USD Million (2019-2024)
  • Table 38. South Korea Skin Boosters, by Gender USD Million (2019-2024)
  • Table 39. Taiwan Skin Boosters, by Type USD Million (2019-2024)
  • Table 40. Taiwan Skin Boosters, by End Users USD Million (2019-2024)
  • Table 41. Taiwan Skin Boosters, by Gender USD Million (2019-2024)
  • Table 42. Australia Skin Boosters, by Type USD Million (2019-2024)
  • Table 43. Australia Skin Boosters, by End Users USD Million (2019-2024)
  • Table 44. Australia Skin Boosters, by Gender USD Million (2019-2024)
  • Table 45. Rest of Asia-Pacific Skin Boosters, by Type USD Million (2019-2024)
  • Table 46. Rest of Asia-Pacific Skin Boosters, by End Users USD Million (2019-2024)
  • Table 47. Rest of Asia-Pacific Skin Boosters, by Gender USD Million (2019-2024)
  • Table 48. Europe Skin Boosters, by Country USD Million (2019-2024)
  • Table 49. Europe Skin Boosters, by Type USD Million (2019-2024)
  • Table 50. Europe Skin Boosters, by End Users USD Million (2019-2024)
  • Table 51. Europe Skin Boosters, by Gender USD Million (2019-2024)
  • Table 52. Germany Skin Boosters, by Type USD Million (2019-2024)
  • Table 53. Germany Skin Boosters, by End Users USD Million (2019-2024)
  • Table 54. Germany Skin Boosters, by Gender USD Million (2019-2024)
  • Table 55. France Skin Boosters, by Type USD Million (2019-2024)
  • Table 56. France Skin Boosters, by End Users USD Million (2019-2024)
  • Table 57. France Skin Boosters, by Gender USD Million (2019-2024)
  • Table 58. Italy Skin Boosters, by Type USD Million (2019-2024)
  • Table 59. Italy Skin Boosters, by End Users USD Million (2019-2024)
  • Table 60. Italy Skin Boosters, by Gender USD Million (2019-2024)
  • Table 61. United Kingdom Skin Boosters, by Type USD Million (2019-2024)
  • Table 62. United Kingdom Skin Boosters, by End Users USD Million (2019-2024)
  • Table 63. United Kingdom Skin Boosters, by Gender USD Million (2019-2024)
  • Table 64. Netherlands Skin Boosters, by Type USD Million (2019-2024)
  • Table 65. Netherlands Skin Boosters, by End Users USD Million (2019-2024)
  • Table 66. Netherlands Skin Boosters, by Gender USD Million (2019-2024)
  • Table 67. Rest of Europe Skin Boosters, by Type USD Million (2019-2024)
  • Table 68. Rest of Europe Skin Boosters, by End Users USD Million (2019-2024)
  • Table 69. Rest of Europe Skin Boosters, by Gender USD Million (2019-2024)
  • Table 70. MEA Skin Boosters, by Country USD Million (2019-2024)
  • Table 71. MEA Skin Boosters, by Type USD Million (2019-2024)
  • Table 72. MEA Skin Boosters, by End Users USD Million (2019-2024)
  • Table 73. MEA Skin Boosters, by Gender USD Million (2019-2024)
  • Table 74. Middle East Skin Boosters, by Type USD Million (2019-2024)
  • Table 75. Middle East Skin Boosters, by End Users USD Million (2019-2024)
  • Table 76. Middle East Skin Boosters, by Gender USD Million (2019-2024)
  • Table 77. Africa Skin Boosters, by Type USD Million (2019-2024)
  • Table 78. Africa Skin Boosters, by End Users USD Million (2019-2024)
  • Table 79. Africa Skin Boosters, by Gender USD Million (2019-2024)
  • Table 80. North America Skin Boosters, by Country USD Million (2019-2024)
  • Table 81. North America Skin Boosters, by Type USD Million (2019-2024)
  • Table 82. North America Skin Boosters, by End Users USD Million (2019-2024)
  • Table 83. North America Skin Boosters, by Gender USD Million (2019-2024)
  • Table 84. United States Skin Boosters, by Type USD Million (2019-2024)
  • Table 85. United States Skin Boosters, by End Users USD Million (2019-2024)
  • Table 86. United States Skin Boosters, by Gender USD Million (2019-2024)
  • Table 87. Canada Skin Boosters, by Type USD Million (2019-2024)
  • Table 88. Canada Skin Boosters, by End Users USD Million (2019-2024)
  • Table 89. Canada Skin Boosters, by Gender USD Million (2019-2024)
  • Table 90. Mexico Skin Boosters, by Type USD Million (2019-2024)
  • Table 91. Mexico Skin Boosters, by End Users USD Million (2019-2024)
  • Table 92. Mexico Skin Boosters, by Gender USD Million (2019-2024)
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Skin Boosters: by Type(USD Million)
  • Table 101. Skin Boosters Mesotherapy , by Region USD Million (2027-2032)
  • Table 102. Skin Boosters Micro-needle , by Region USD Million (2027-2032)
  • Table 103. Skin Boosters: by End Users(USD Million)
  • Table 104. Skin Boosters Dermatology Clinics , by Region USD Million (2027-2032)
  • Table 105. Skin Boosters Medspas , by Region USD Million (2027-2032)
  • Table 106. Skin Boosters: by Gender(USD Million)
  • Table 107. Skin Boosters Female , by Region USD Million (2027-2032)
  • Table 108. Skin Boosters Male , by Region USD Million (2027-2032)
  • Table 109. South America Skin Boosters, by Country USD Million (2027-2032)
  • Table 110. South America Skin Boosters, by Type USD Million (2027-2032)
  • Table 111. South America Skin Boosters, by End Users USD Million (2027-2032)
  • Table 112. South America Skin Boosters, by Gender USD Million (2027-2032)
  • Table 113. Brazil Skin Boosters, by Type USD Million (2027-2032)
  • Table 114. Brazil Skin Boosters, by End Users USD Million (2027-2032)
  • Table 115. Brazil Skin Boosters, by Gender USD Million (2027-2032)
  • Table 116. Argentina Skin Boosters, by Type USD Million (2027-2032)
  • Table 117. Argentina Skin Boosters, by End Users USD Million (2027-2032)
  • Table 118. Argentina Skin Boosters, by Gender USD Million (2027-2032)
  • Table 119. Rest of South America Skin Boosters, by Type USD Million (2027-2032)
  • Table 120. Rest of South America Skin Boosters, by End Users USD Million (2027-2032)
  • Table 121. Rest of South America Skin Boosters, by Gender USD Million (2027-2032)
  • Table 122. Asia Pacific Skin Boosters, by Country USD Million (2027-2032)
  • Table 123. Asia Pacific Skin Boosters, by Type USD Million (2027-2032)
  • Table 124. Asia Pacific Skin Boosters, by End Users USD Million (2027-2032)
  • Table 125. Asia Pacific Skin Boosters, by Gender USD Million (2027-2032)
  • Table 126. China Skin Boosters, by Type USD Million (2027-2032)
  • Table 127. China Skin Boosters, by End Users USD Million (2027-2032)
  • Table 128. China Skin Boosters, by Gender USD Million (2027-2032)
  • Table 129. Japan Skin Boosters, by Type USD Million (2027-2032)
  • Table 130. Japan Skin Boosters, by End Users USD Million (2027-2032)
  • Table 131. Japan Skin Boosters, by Gender USD Million (2027-2032)
  • Table 132. India Skin Boosters, by Type USD Million (2027-2032)
  • Table 133. India Skin Boosters, by End Users USD Million (2027-2032)
  • Table 134. India Skin Boosters, by Gender USD Million (2027-2032)
  • Table 135. South Korea Skin Boosters, by Type USD Million (2027-2032)
  • Table 136. South Korea Skin Boosters, by End Users USD Million (2027-2032)
  • Table 137. South Korea Skin Boosters, by Gender USD Million (2027-2032)
  • Table 138. Taiwan Skin Boosters, by Type USD Million (2027-2032)
  • Table 139. Taiwan Skin Boosters, by End Users USD Million (2027-2032)
  • Table 140. Taiwan Skin Boosters, by Gender USD Million (2027-2032)
  • Table 141. Australia Skin Boosters, by Type USD Million (2027-2032)
  • Table 142. Australia Skin Boosters, by End Users USD Million (2027-2032)
  • Table 143. Australia Skin Boosters, by Gender USD Million (2027-2032)
  • Table 144. Rest of Asia-Pacific Skin Boosters, by Type USD Million (2027-2032)
  • Table 145. Rest of Asia-Pacific Skin Boosters, by End Users USD Million (2027-2032)
  • Table 146. Rest of Asia-Pacific Skin Boosters, by Gender USD Million (2027-2032)
  • Table 147. Europe Skin Boosters, by Country USD Million (2027-2032)
  • Table 148. Europe Skin Boosters, by Type USD Million (2027-2032)
  • Table 149. Europe Skin Boosters, by End Users USD Million (2027-2032)
  • Table 150. Europe Skin Boosters, by Gender USD Million (2027-2032)
  • Table 151. Germany Skin Boosters, by Type USD Million (2027-2032)
  • Table 152. Germany Skin Boosters, by End Users USD Million (2027-2032)
  • Table 153. Germany Skin Boosters, by Gender USD Million (2027-2032)
  • Table 154. France Skin Boosters, by Type USD Million (2027-2032)
  • Table 155. France Skin Boosters, by End Users USD Million (2027-2032)
  • Table 156. France Skin Boosters, by Gender USD Million (2027-2032)
  • Table 157. Italy Skin Boosters, by Type USD Million (2027-2032)
  • Table 158. Italy Skin Boosters, by End Users USD Million (2027-2032)
  • Table 159. Italy Skin Boosters, by Gender USD Million (2027-2032)
  • Table 160. United Kingdom Skin Boosters, by Type USD Million (2027-2032)
  • Table 161. United Kingdom Skin Boosters, by End Users USD Million (2027-2032)
  • Table 162. United Kingdom Skin Boosters, by Gender USD Million (2027-2032)
  • Table 163. Netherlands Skin Boosters, by Type USD Million (2027-2032)
  • Table 164. Netherlands Skin Boosters, by End Users USD Million (2027-2032)
  • Table 165. Netherlands Skin Boosters, by Gender USD Million (2027-2032)
  • Table 166. Rest of Europe Skin Boosters, by Type USD Million (2027-2032)
  • Table 167. Rest of Europe Skin Boosters, by End Users USD Million (2027-2032)
  • Table 168. Rest of Europe Skin Boosters, by Gender USD Million (2027-2032)
  • Table 169. MEA Skin Boosters, by Country USD Million (2027-2032)
  • Table 170. MEA Skin Boosters, by Type USD Million (2027-2032)
  • Table 171. MEA Skin Boosters, by End Users USD Million (2027-2032)
  • Table 172. MEA Skin Boosters, by Gender USD Million (2027-2032)
  • Table 173. Middle East Skin Boosters, by Type USD Million (2027-2032)
  • Table 174. Middle East Skin Boosters, by End Users USD Million (2027-2032)
  • Table 175. Middle East Skin Boosters, by Gender USD Million (2027-2032)
  • Table 176. Africa Skin Boosters, by Type USD Million (2027-2032)
  • Table 177. Africa Skin Boosters, by End Users USD Million (2027-2032)
  • Table 178. Africa Skin Boosters, by Gender USD Million (2027-2032)
  • Table 179. North America Skin Boosters, by Country USD Million (2027-2032)
  • Table 180. North America Skin Boosters, by Type USD Million (2027-2032)
  • Table 181. North America Skin Boosters, by End Users USD Million (2027-2032)
  • Table 182. North America Skin Boosters, by Gender USD Million (2027-2032)
  • Table 183. United States Skin Boosters, by Type USD Million (2027-2032)
  • Table 184. United States Skin Boosters, by End Users USD Million (2027-2032)
  • Table 185. United States Skin Boosters, by Gender USD Million (2027-2032)
  • Table 186. Canada Skin Boosters, by Type USD Million (2027-2032)
  • Table 187. Canada Skin Boosters, by End Users USD Million (2027-2032)
  • Table 188. Canada Skin Boosters, by Gender USD Million (2027-2032)
  • Table 189. Mexico Skin Boosters, by Type USD Million (2027-2032)
  • Table 190. Mexico Skin Boosters, by End Users USD Million (2027-2032)
  • Table 191. Mexico Skin Boosters, by Gender USD Million (2027-2032)
  • Table 192. Research Programs/Design for This Report
  • Table 193. Key Data Information from Secondary Sources
  • Table 194. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Skin Boosters: by Type USD Million (2019-2024)
  • Figure 5. Global Skin Boosters: by End Users USD Million (2019-2024)
  • Figure 6. Global Skin Boosters: by Gender USD Million (2019-2024)
  • Figure 7. South America Skin Boosters Share (%), by Country
  • Figure 8. Asia Pacific Skin Boosters Share (%), by Country
  • Figure 9. Europe Skin Boosters Share (%), by Country
  • Figure 10. MEA Skin Boosters Share (%), by Country
  • Figure 11. North America Skin Boosters Share (%), by Country
  • Figure 12. Global Skin Boosters share by Players 2024 (%)
  • Figure 13. Global Skin Boosters share by Players (Top 3) 2024(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Bloomage Biotech Co., Ltd. (China)​ Revenue, Net Income and Gross profit
  • Figure 16. Bloomage Biotech Co., Ltd. (China)​ Revenue: by Geography 2024
  • Figure 17. Medytox, Inc. (South Korea)​ Revenue, Net Income and Gross profit
  • Figure 18. Medytox, Inc. (South Korea)​ Revenue: by Geography 2024
  • Figure 19. AbbVie Inc. (United States)​ Revenue, Net Income and Gross profit
  • Figure 20. AbbVie Inc. (United States)​ Revenue: by Geography 2024
  • Figure 21. Merz Pharma (Germany)​ Revenue, Net Income and Gross profit
  • Figure 22. Merz Pharma (Germany)​ Revenue: by Geography 2024
  • Figure 23. Galderma (Switzerland)​ Revenue, Net Income and Gross profit
  • Figure 24. Galderma (Switzerland)​ Revenue: by Geography 2024
  • Figure 25. Teoxane (Switzerland) ​ Revenue, Net Income and Gross profit
  • Figure 26. Teoxane (Switzerland) ​ Revenue: by Geography 2024
  • Figure 27. IBSA Farmaceutici Italia Srl (Italy) ​ Revenue, Net Income and Gross profit
  • Figure 28. IBSA Farmaceutici Italia Srl (Italy) ​ Revenue: by Geography 2024
  • Figure 29. Global Skin Boosters: by Type USD Million (2027-2032)
  • Figure 30. Global Skin Boosters: by End Users USD Million (2027-2032)
  • Figure 31. Global Skin Boosters: by Gender USD Million (2027-2032)
  • Figure 32. South America Skin Boosters Share (%), by Country
  • Figure 33. Asia Pacific Skin Boosters Share (%), by Country
  • Figure 34. Europe Skin Boosters Share (%), by Country
  • Figure 35. MEA Skin Boosters Share (%), by Country
  • Figure 36. North America Skin Boosters Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bloomage Biotech Co., Ltd. (China)​
  • Medytox, Inc. (South Korea)​
  • AbbVie Inc. (United States)​
  • Merz Pharma (Germany)​
  • Galderma (Switzerland)​
  • Teoxane (Switzerland) ​
  • IBSA Farmaceutici Italia Srl (Italy) ​
Additional players considered in the study are as follows:
PharmaResearch Co., Ltd. (South Korea)​ , Allergan ( Ireland)​ , IBSA Institut Biochimique SA (Switzerland)​ , HA Derma Filler (South Korea)​ , Filorga Laboratories (France)
Select User Access Type

Key Highlights of Report


Apr 2025 240 Pages 50 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Know More About Global Skin Boosters Market Report?